secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001171843-25-007972
Event type: debt
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 1.02, 2.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience closes $40M debt refinancing with BroadOak; extends maturity to 2029, appoints new director
--------------------------------------------------------------------------------

- Enters $40M senior secured credit facility (Term A $10M, Term B $22.5M, Term C $7.5M convertible at $1.00) maturing Dec 17, 2029
- Issues warrants to purchase 2M shares of common stock at $0.50 per share; proceeds repay existing Citizens Bank credit facility
- Quarterly amortization on Term A/B begins Dec 31, 2027; amortization and maturity can extend 1 year upon EBITDA milestone
- Appoints Bill Snider (BroadOak Partner) to Board and Compensation Committee; will form Product, Operations & Scientific Advisory Board

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/0001171843-25-007972-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/f8k_121625.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-007972

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer